期刊文献+

肥胖和肥胖抵抗大鼠脂肪组织PPARγ和aP2基因表达的研究 被引量:8

Study on PPARγ and aP2 mRNA expression of adipose tissues in obesity and obesity resistant rats
原文传递
导出
摘要 目的观察高脂饮食诱导的肥胖及肥胖抵抗大鼠脂肪组织中PPARγ和aP2 mRNA表达水平的变化。方法31只健康wistar雄性大鼠,随机选取7只作为对照组喂饲基础饲料,24只作为高脂组喂饲高脂饲料。第8周末按体重增量,从高脂组选出5只大鼠作为肥胖组,5只作为肥胖抵抗组,检测各组大鼠血清甘油三酯和总胆固醇,附睾周围脂肪组织中PPARγ和aP2 mRNA表达。结果肥胖组大鼠血清甘油三酯水平显著高于对照组(P<0.05);总胆固醇水平均显著高于对照组和肥胖抵抗组(P<0.05,P<0.01);肥胖组PPARγ和aP2 mRNA表达量高于对照组和肥胖抵抗组(P<0.05)。结论高脂饮食诱导产生的肥胖及肥胖抵抗大鼠在脂肪组织PPARγ和aP2 mRNA表达上存在差异,肥胖大鼠脂肪合成能力增强。 Objective To observe the difference of serum triglyceride, total cholesterol levels and expression of PPARγ and aP2 mRNA of adipose tissues between obesity and obesity resistant rats induced by high-fat diet. Methods Thirty-one healthy male Wistar rats were randomly divided into two groups. Seven of them were fed with standard diet as control group and 24 rats were fed with high-fat diet as high-fat group. At the end of the 8th week, according to the body weight increment, five rats were selected as obesity group, and five rats were selected as obesity resistant group from highfat feeding rats. Serum trlglyceride, total cholesterol, and the expressions of PPARγ and aP2 mRNA of epididymal adipose tissues were detected. Results Serum triglyceride of obesity group were higher than those of control ( P 〈 0.05). Total cholesterol levels of obesity group were higher than those of control and obesity resistant group ( P 〈 0.05, P 〈 0.01 ). The expressions of PPARγ and aP2 mRNA of obesity group were also much higher than those of control and obesity resistant group. Conclusion The expressions of PPARγ and aP2 mRNA of obesity and obesity resistant rats induced by high-fat diet existed difference.
出处 《卫生研究》 CAS CSCD 北大核心 2009年第2期163-165,共3页 Journal of Hygiene Research
基金 国家自然科学基金资助项目(No.30500409)
关键词 肥胖 肥胖抵抗 过氧化物酶体增殖物激活受体Γ 脂肪酸结合蛋白 obesity, obesity resistant, peroxisome proliferators activated receptor-γ, adipocyte fatty-acid-binding protein
  • 相关文献

参考文献7

  • 1PICARD F, KURTEV M, CHUNG N, et al. Sirtl promotes fat mobilization in white adipocytes by repressing PPAR-gamma[J]. Nature, 2004, 429(6993) : 771-776.
  • 2TAKASAWA K, KUBOTA N, TERAUCHI Y, et al. Impact of increased PPAR gamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment[J]. Endocr J, 2008, 55(4) : 767-776.
  • 3LAPLANTE M, FESTUCCIA W T, SOUCY G, et al. Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism[J]. Diabetes, 2006, 55(10) : 2771- 2778.
  • 4HERTZ'EL AV, BERNLOHR D A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function[ J ]. Trends Endocrinol Metab, 2000, 11(5) : 175-180.
  • 5TUNCMAN G, ERBAY E, HOM X, et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyeeridemia, type 2 diabetes, and cardiovascular disease[J]. Proc Nail Acad Sci U S A, 2006, 103(18): 6970-6975.
  • 6MAEDA K, CAO H, KONO K, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes[J]. Cell Metab, 2005, 1(2) :107-119.
  • 7FURUHASHI M, TUNCMAN G, GORGUN C Z, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 [J]. Nature, 2007, 447(7147): 959-965.

同被引文献99

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部